Endocrine Abstracts

Objective: To describe the experience of patients with differentiated thyroid carcinoma (DTC) since their diagnosis.Patients and Methods: Cross-sectional study including 25 patients with DTC who integrated the therapeutic education program (TPE) on DTC at the Nuclear Medicine Center, Sfax, Tunisia. Each participant recounted his or her experience during collective meetings (narrative approach). Results: Our group was composed of 19...

Objective: to evaluate the fear of recurrence of differentiated thyroid cancer (DTC) in patients in complete remission. Patients and Methods: Cross-sectional study of 41 patients in complete remission after treatment of DTC, followed up at the Nuclear Medicine Centre of Sfax, Tunisia. The evaluation was based on the administration of a shortened version of the Fear of Cancer Recurrence Inventory (FCRI-SF) to all patients (maximum score 36 points)<p c...

Objective: To evaluate the quality of sleep in patients in remission of differentiated thyroid cancer (DTC) Patients and Methods: Comparative case-control study conducted at the Nuclear Medicine Center of Sfax, Tunisia including 99 individuals divided into 2 subgroups G1 (n=39) patients in remission from DTC G2 (n=60) healthy control subjects Sleep quality was assessed according to the 7 components of the Pittsburgh Sleep Quality Index ...

Objective: To assess the educational needs of patients with differentiated thyroid carcinoma (DTC) undergoing ablative irradiation therapy (RAI131)Patients and Methods: Cross-sectional study including 25 patients operated for TDC who integrated the therapeutic education program (TPE) on DTC at the Nuclear Medicine Center, Sfax, Tunisia. An assessment questionnaire was filled by the patients before the RAI session131Results: Our gro...

Objective: To determine the prevalence and factors associated with sleep disorders in patients with differentiated thyroid cancer (DTC)Patients and Methods: Analytical cross-sectional study of 39 patients followed for DTC at the Nuclear Medicine Center of Sfax, Tunisia. Sleep disorders were evaluated according to the 7 components of the Pittsburgh Sleep Quality Index (PSQI). Results: The average age of the patients at the time of t...

Introduction: Primary adrenal lymphoma (PAL) is a very rare entity. Less than 200 cases have been reported. Its evolution is unfavourable even under treatment. We report a case of PAL with a falsely reassuring course unmasked by 18F-FDG PET-CT.Observation: This is a 48-year-old female patient hospitalized with altered general condition, weight loss, fever and cytopenias. The initial thoraco-abdomino-pelvic CT scan revealed two large bilateral adrenal tum...

Objective: To study the carcinological factors associated with adrenal metastases (AMT) in bronchopulmonary cancer (PBC).Patients and Methods Case–control study analysing oncological data of 40 patients with PBC monitored by 18DFG PET/CT at the Nuclear Medicine Centre of Sfax, Tunisia. We compare the characteristics of 2 subgroups:G1 (n=17): patients with PBC and META (cases)G2 (n=23): ...

Thyroid differentiated carcinomas are of good prognosis except in case of metastatic dissemination. These distant metastasis, especially the bone one, are a major cause of altered quality of life and death. This study concerns a cohort of 21 patients treated from 1995 to 2011.The aim of our work is to study the characteristics of patients who had bone metastases in association with thyroid cancer to determine their prognostic factors. 18 of our patients were ...

IntroductionDifferentiated thyroid cancer (DTC) is the most common thyroid cancer with a relatively high survival rate. Distant metastasis (DM) is not a frequent event in DTC but has an adverse impact on mortality of patients.PurposeThe aim of this study was to determine the most frequent metastases and their prognosis after adequate treatment.MethodsA retrospecti...

IntroductionDifferentiated thyroid cancer (DTC) is a rare disease (1%), and usually has good prognosis if well treated. However, the percentage of mortality due to this cancer is about 0.5%. Moreover, 5 to 27%of patients treated for DTC suffer from regional recurrence. Therefore, many research tried to identify predective factors for the survival, relapse and progression of this cancer.PurposeThe aim of our s...